Results 91 to 100 of about 1,471,694 (149)
Cytoreduction and Hyperthermic Intrathoracic Chemotherapy for Metastatic Pseudomyxoma Peritonei
Pleural extension of pseudomyxoma peritonei is rare, and treatment demands multidisciplinary care. Perioperative management during cytoreductive surgery and hyperthermic intrathoracic chemotherapy challenges anesthesiology and surgical teams in unique ...
Luke J. Matzek, MD +7 more
doaj +1 more source
Overall (OS) and disease-free survival (DFS) after complete cytoreductive surgery in patients with DSRCT without extra-peritoneal metastases.
A. LeCesne (3778477) +19 more
core +1 more source
ABSTRACT In a patient with advanced ovarian cancer showing limited response to paclitaxel–carboplatin, adding sintilimab was associated with R0 cytoreduction and sustained disease‐free status during olaparib–bevacizumab maintenance. This case provides a rationale for further investigation of PD‐1 blockade as neoadjuvant therapy in carefully selected ...
Wang Zhenyan, Wang Yan
wiley +1 more source
Background This study aimed to determine the effect of neoadjuvant chemotherapy (NACT) on the complex surgical procedures required in addition to staging surgery for the need to achieve a residual tumor 1 cm or less in a population of stage IIIC–IV ...
Okan Aytekin +8 more
doaj +1 more source
Peritoneal Metastatic Gastric Cancer: Local Treatment Options and Recommendations
Peritoneal metastasis is a common finding in patients with advanced gastric cancer. Beyond systemic chemotherapy, additive local treatments such as cytoreductive surgery and intraperitoneal chemotherapy are considered an inherent part of different ...
Miklos Acs +2 more
doaj +1 more source
Hsin-Hsien Yu,1,2 Yutaka Yonemura,3,4 Mao-Chih Hsieh,2,5 Chang-Yun Lu,2 Szu-Yuan Wu,6,7 Yan-Shen Shan1,8 1Institute of Clinical Medicine, College of Medicine, National Cheng Kung University, Tainan, Taiwan; 2Division of General Surgery, Department of ...
Wu SY +5 more
core
Corrigendum to ‘A preoperative personalized risk assessment calculator for elderly ovarian cancer patients undergoing primary cytoreductive surgery’ Gynecol. Oncol. 139 (2015) start 401–406 [PDF]
Corrigendum to "A preoperative personalized risk assessment calculator for elderly ovarian cancer patients undergoing primary cytoreductive ...
Barber, Emma L. +3 more
core +1 more source
ABSTRACT Persistent symptoms suggestive of idiopathic intracranial hypertension despite standard therapy should prompt urgent neuroimaging to exclude cerebral venous sinus thrombosis. When CVST is confirmed without an obvious provoking factor, evaluation for underlying myeloproliferative neoplasms, including JAK2‐positive essential thrombocythemia, is ...
Sarah Nafea +6 more
wiley +1 more source
Cytoreductive surgery for men with metastatic prostate cancer
Background: Cytoreductive surgery for metastatic prostate cancer is an emerging area of interest with a potential upside that includes local control, delayed initiation of hormone therapy, and possibly improved cancer specific survival.
Nikolas Katelaris +4 more
doaj +1 more source
Rationale and techniques of cytoreductive surgery and peritoneal chemohyperthermia.
The evolution of loco-regional treatments has occurred in the last two decades and has deeply changed the natural history of primitive and secondary peritoneal surface malignancies.
Fortugno A, MACRI', Antonio, Saladino E.
core

